Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy-Reference-Cited by-同舟云学术

Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy

Published:2022-09 Issue:5 Volume:21 Page:617-625
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Andruska Neal^ORCID,Agabalogun Temitope,Fischer-Valuck Benjamin W.,Brenneman Randall J.^ORCID,Huang Yi^ORCID,Gay Hiram A.^ORCID,Michalski Jeff M.,Carmona Ruben,Baumann Brian C.^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference25 articles.

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): Prostate cancer (version 2.2021). https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed March 2, 2021.

2. Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer;Dinh;J Urol,2015

3. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014

4. Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG oncology RTOG 0126 randomized clinical trial;Michalski;JAMA Oncol,2018

5. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09;Zietman;J Clin Oncol,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone Deprivation–Free Survival—Inequities Persist in Research Priorities for Patients With Cancer;JAMA Oncology;2024-07-25

2. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer;European Urology Oncology;2023-12

3. Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer;Cancer Urology;2023-05-13